Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
684.5 CHF | -1.23% |
|
-2.83% | +40.38% |
Jul. 16 | Aclaris Therapeutics Sells Olumiant Royalties, Milestone Payments From Eli Lilly | MT |
Jul. 16 | Goldman Sachs Adjusts Price Target on Eli Lilly to $812 From $793 | MT |
Chart: Technical Analysis
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- LLY Stock
- LLY Stock
- Charts Eli Lilly and Company